A facility must be more than capable of manufacturing viral vectors at a commercial scale. It should be designed to operate smoothly, cost-effectively, and with maximum efficiency. This requires a close examination of assumptions and decisions.
As the industry gallops forward, some will succeed in the lab but struggle to scale. Others will design sophisticated processes that accomplish what no facility has accomplished before but at such a high cost per square foot that they’ll struggle to reach profitability. The real test will come in five years when we survey those who are left standing. What choices are those “survivors” making right now, in their early stages of growth, to de-risk their future production?
To answer that question, this webinar explores:
- The viral vector industry
- The science of viral vectors
- The manufacturing process
- The optimal facility design for different viral vector types
- The future of the technology
Listen to the webinar to understand the interdependent factors that contribute to an efficient and reliable throughput of viral vector products at a commercial scale.